Precigen PGEN
NASDAQ PGEN
$4.73 +0.26 (+5.82%)
At close: Nov 9, 2026 · 4:00 PM EST

Precigen (PGEN) EBITDA Margin (2012 - 2026)

Updated

Precigen (PGEN) posted EBITDA Margin of 43.19% for Q2 2026, up 3680.34 percentage points from -3637.15% a year earlier and up 64.24 percentage points from the prior quarter.

Analysis

Precigen (PGEN) EBITDA Margin (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Precigen was -41.25%, up 2298.47 percentage points year-over-year; for FY2025, it came in at -1108.10%, up 2216.82 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of -1052.92 percentage points (FY2020 to FY2025).
  • In prior years, Precigen's EBITDA Margin was -3324.92% in FY2024 (-1829.50 pp), -1495.42% in FY2023 (-1254.01 pp), -241.41% in FY2022 (+306.62 pp) and -548.03% in FY2021 (-492.85 pp).
  • The Q2 2026 figure stands as the highest quarterly EBITDA Margin in data going back to Q2 2012.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last seven quarters, with an average year-over-year change of +1609.90 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2025, with a gain of 4625.75 percentage points; the weakest was Q2 2024, with a drop of 7163.47 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -21.05% (Q1 2026), -449.70% (Q4 2025) and -1152.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 32.68%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 46.88%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 40.75%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 39.77%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 46.62%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 50.63%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 42.49%
10 Precigen 1.70 Bn 1.46 Bn 67.64 Mn 54.13%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 54.13%
Jun 30, 2026 43.84%
Mar 31, 2026 -19.57%
Dec 31, 2025 -443.48%
Sep 30, 2025 -1,150.10%
Jun 30, 2025 -3,637.15%
Mar 31, 2025 -1,638.11%
Dec 31, 2024 -2,340.76%
Sep 30, 2024 -2,160.34%
Jun 30, 2024 -8,262.90%
Mar 31, 2024 -2,142.25%
Dec 31, 2023 -2,655.54%
Sep 30, 2023 -1,398.62%
Jun 30, 2023 -1,097.96%
Mar 31, 2023 -1,174.12%
Dec 31, 2022 -1,132.61%
Sep 30, 2022 -28.41%
Jun 30, 2022 -708.49%
Mar 31, 2022 -336.97%
Dec 31, 2021 -419.63%
API Access

Precigen EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PGEN&period=max&api_key=YOUR_API_KEY